Kirkland & Ellis advised Bristol Myers Squibb Company on the offering, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as sales agent. Alector, Inc. (“Alector”) (Nasdaq:ALEC)...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advided the dealer manager and solicitation agent on the deal. Indie Semiconductor (NASDAQ: INDI) (the “Company”) announced it has completed its exchange offer...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising MSCI Inc. on the transaction. MSCI Inc. announced the acquisition of Trove Research, a specialist data, analysis and advisory firm. The...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising NICE and Kirkland & Ellis is advising LiveVox on the transaction. NICE (NASDAQ: NICE) announced its acquisition of LiveVox (NASDAQ: LVOX), a leading AI-driven proactive...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering. AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Trinity Industries, Inc. in the offering. Trinity Industries, Inc. (NYSE: TRN) (“Trinity” or the “Company”) announced its Rule 144A / Regulation S...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
You must be a Standard 1 Year member to access this content.
Meitar and Cooley advised Gamida Cell on the offering, and Davis Polk advised the underwriter. Gamida Cell Ltd. announced the $23 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop advised Nikola, Davis Polk advised the underwriter and placement agent, and Milbank advised Antara Capital Master Fund LP. Nikola Corporation announced an SEC-registered public...
You must be a Standard 1 Year member to access this content.
White & Case advised Ormat, and Davis Polk advised the sole book-running manager. Ormat Technologies, Inc. announced an SEC-registered follow-on offering of 3,600,000 shares of common...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Eli Lilly, and Davis Polk advised the joint book-running managers for the offering. Eli Lilly and Company announced a registered offering of...
You must be a Standard 1 Year member to access this content.
